Anti-FETUA/ AHSG/ A2HS functional antibody

Anti-FETUA/ AHSG/ A2HS functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to AHSG/AHSG products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T45289-Ab-1/ GM-Tg-hg-T45289-Ab-2Anti-Human AHSG monoclonal antibodyHuman
GM-Tg-rg-T45289-Ab-1/ GM-Tg-rg-T45289-Ab-2Anti-Rat AHSG monoclonal antibodyRat
GM-Tg-mg-T45289-Ab-1/ GM-Tg-mg-T45289-Ab-2Anti-Mouse AHSG monoclonal antibodyMouse
GM-Tg-cynog-T45289-Ab-1/ GM-Tg-cynog-T45289-Ab-2Anti-Cynomolgus/ Rhesus macaque AHSG monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T45289-Ab-1/ GM-Tg-felg-T45289-Ab-2Anti-Feline AHSG monoclonal antibodyFeline
GM-Tg-cang-T45289-Ab-1/ GM-Tg-cang-T45289-Ab-2Anti-Canine AHSG monoclonal antibodyCanine
GM-Tg-bovg-T45289-Ab-1/ GM-Tg-bovg-T45289-Ab-2Anti-Bovine AHSG monoclonal antibodyBovine
GM-Tg-equg-T45289-Ab-1/ GM-Tg-equg-T45289-Ab-2Anti-Equine AHSG monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T45289-Ab-1/ GM-Tg-hg-T45289-Ab-2; GM-Tg-rg-T45289-Ab-1/ GM-Tg-rg-T45289-Ab-2;
GM-Tg-mg-T45289-Ab-1/ GM-Tg-mg-T45289-Ab-2; GM-Tg-cynog-T45289-Ab-1/ GM-Tg-cynog-T45289-Ab-2;
GM-Tg-felg-T45289-Ab-1/ GM-Tg-felg-T45289-Ab-2; GM-Tg-cang-T45289-Ab-1/ GM-Tg-cang-T45289-Ab-2;
GM-Tg-bovg-T45289-Ab-1/ GM-Tg-bovg-T45289-Ab-2; GM-Tg-equg-T45289-Ab-1/ GM-Tg-equg-T45289-Ab-2
Products NameAnti-AHSG monoclonal antibody
Formatmab
Target NameAHSG
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-AHSG benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T45289-Ag-1Recombinant multi-species FETUA/ AHSG/ A2HS protein
    ORF Viral VectorpGMLPm003808mouse Ahsg Lentivirus plasmid
    ORF Viral VectorvGMLPm003808mouse Ahsg Lentivirus particle


    Target information

    Target IDGM-T45289
    Target NameAHSG
    Gene ID197,11625,25373,699348,607538,101099828,280988,100068067
    Gene Symbol and SynonymsA2HS,Aa2-066,AHS,AHSG,APMR1,BSP,FETUA,HSGA,pp63
    Uniprot AccessionP02765,P24090,P12763
    Uniprot Entry NameFETUA_HUMAN,FETUA_RAT,FETUA_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    CategoryTherapeutics Target
    Diseaseleukemia patients, Diabetic Nephropathy, Type 2 diabetes mellitus
    Gene EnsemblENSG00000145192
    Target ClassificationN/A

    The target: AHSG, gene name: AHSG, also named as A2HS, AHS, APMR1, FETUA, HSGA. The protein encoded by this gene is a negatively-charged serum glycoprotein that is synthesized by hepatocytes. The encoded protein consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several processes, including endocytosis, brain development, and the formation of bone tissue. Defects in this gene are a cause of susceptibility to leanness. [provided by RefSeq, Aug 2017].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.